{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:12:43Z","timestamp":1791396763877,"version":"4.3.3"},"reference-count":208,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AA-11431 and AA-12908"],"award-info":[{"award-number":["AA-11431 and AA-12908"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bcp.2013.12.012","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T03:46:43Z","timestamp":1388807203000},"page":"548-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":417,"title":["Brain metabolic dysfunction at the core of Alzheimer's disease"],"prefix":"10.1016","volume":"88","author":[{"given":"Suzanne M.","family":"de la Monte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2013.12.012_bib0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000212758","article-title":"Obesity, inflammation, and insulin resistance \u2013 a mini-review","volume":"55","author":"Zeyda","year":"2009","journal-title":"Gerontology"},{"key":"10.1016\/j.bcp.2013.12.012_bib0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ecl.2012.04.018","article-title":"Insulin-like growth factors in the gastrointestinal tract and liver","volume":"41","author":"Kuemmerle","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.bcp.2013.12.012_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","article-title":"Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease","volume":"7","author":"de la Monte","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0020","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1210\/en.2008-0920","article-title":"Expanding the mind: insulin-like growth factor I and brain development","volume":"149","author":"D\u2019Ercole","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2013.12.012_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156720509788486527","article-title":"The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease","volume":"6","author":"Freude","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0030","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/glia.20469","article-title":"Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination","volume":"55","author":"Zeger","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2013.12.012_bib0035","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/ijerph6072055","article-title":"The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids","volume":"6","author":"de la Monte","year":"2009","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.bcp.2013.12.012_bib0040","first-page":"1049","article-title":"Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis","volume":"10","author":"de la Monte","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2013.12.012_bib0045","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2013.12.012_bib0050","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2337\/dc09-0153","article-title":"Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report","volume":"32","author":"Dankner","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2013.12.012_bib0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2009.10.030","article-title":"Hyperinsulinemia is a predictor of new cardiovascular events in Colombian patients with a first myocardial infarction","volume":"148","author":"Garcia","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0060","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/HJH.0b013e32832961cf","article-title":"The adverse prognostic significance of the metabolic syndrome with and without hypertension in patients who underwent complete coronary revascularization","volume":"27","author":"Kasai","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.bcp.2013.12.012_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.numecd.2009.02.006","article-title":"Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study","volume":"20","author":"Agnoli","year":"2010","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/CCO.0b013e32834e0582","article-title":"Metabolic diseases and cancer risk","volume":"24","author":"Faulds","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-011-1790-x","article-title":"A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor","volume":"131","author":"Colonna","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bcp.2013.12.012_bib0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bcp.2013.12.012_bib0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","article-title":"Glucose metabolism and insulin receptor signal transduction in Alzheimer disease","volume":"490","author":"Hoyer","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease \u2013 is this type 3 diabetes","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0100","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2741\/e482","article-title":"Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease","volume":"E4","author":"de la Monte","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0105","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.3233\/JAD-2012-111728","article-title":"Dysfunctional pro-ceramide, ER stress, and insulin\/IGF signaling networks with progression of Alzheimer's disease","volume":"30","author":"de la Monte","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0110","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archneurol.2008.1","article-title":"Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment","volume":"65","author":"Caselli","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease","volume":"1147","author":"Mosconi","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0120","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archneurol.2010.30","article-title":"Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele","volume":"67","author":"Langbaum","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01258634","article-title":"Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type","volume":"75","author":"Hoyer","year":"1989","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bcp.2013.12.012_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02251132","article-title":"Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases","volume":"3","author":"Hoyer","year":"1991","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1016\/j.bcp.2013.12.012_bib0135","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2013.12.012_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","article-title":"Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease","volume":"9","author":"Lester-Coll","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00702-003-0058-y","article-title":"Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity","volume":"111","author":"Weinstock","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bcp.2013.12.012_bib0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1383-5742(02)00044-3","article-title":"Genotoxicity of streptozotocin","volume":"512","author":"Bolzan","year":"2002","journal-title":"Mutat Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-6143.2003.00040.x","article-title":"The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis)","volume":"3","author":"Koulmanda","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bcp.2013.12.012_bib0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-6606-4-13","article-title":"si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder","volume":"4","author":"de la Monte","year":"2011","journal-title":"Mol Brain"},{"key":"10.1016\/j.bcp.2013.12.012_bib0165","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1476-5381.2012.01971.x","article-title":"Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders","volume":"166","author":"Salcedo","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.exger.2010.08.022","article-title":"IGF-I and the aging mammalian brain","volume":"46","author":"Piriz","year":"2011","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0175","first-page":"5","article-title":"The impact of dietary energy intake on cognitive aging","volume":"2","author":"Mattson","year":"2010","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0180","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2013.12.012_bib0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bss0670089","article-title":"Presenilin function: connections to Alzheimer's disease and signal transduction","volume":"67","author":"Fraser","year":"2001","journal-title":"Biochem Soc Symp"},{"key":"10.1016\/j.bcp.2013.12.012_bib0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000258724","article-title":"Neuroimmunomodulation in the pathogenesis of Alzheimer's disease","volume":"17","author":"Morales","year":"2010","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bcp.2013.12.012_bib0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-009-0486-3","article-title":"Alonso Adel C, Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration","volume":"118","author":"Iqbal","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0205","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.12.012_bib0210","first-page":"177","article-title":"Drug development for tauopathy and Alzheimer's disease","volume":"30","author":"Takashima","year":"2010","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"10.1016\/j.bcp.2013.12.012_bib0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000095638","article-title":"It may take inflammation, phosphorylation and ubiquitination to \u2018tangle\u2019 in Alzheimer's disease","volume":"3","author":"Arnaud","year":"2006","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0220","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1582-4934.2008.00276.x","article-title":"The ubiquitin-proteasome system in Alzheimer's disease","volume":"12","author":"Oddo","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0225","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2003.04.007","article-title":"Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses","volume":"24","author":"Mandelkow","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bcp.2013.12.012_bib0230","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s00018-003-3305-3","article-title":"Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells","volume":"60","author":"de la Monte","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0235","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0240","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neurobiolaging.2010.05.022","article-title":"Mechanisms of AD neurodegeneration may be independent of Abeta and its derivatives","volume":"32","author":"Robakis","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bcp.2013.12.012_bib0245","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0317167100013949","article-title":"Early-onset familial Alzheimer's disease (EOFAD)","volume":"39","author":"Wu","year":"2012","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0250","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis","volume":"15","author":"Bosco","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0162-3109(97)00067-2","article-title":"Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide","volume":"38","author":"Emmerling","year":"1997","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bcp.2013.12.012_bib0260","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1474-9728.2004.00101.x","article-title":"How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes","volume":"3","author":"Blasko","year":"2004","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2013.12.012_bib0265","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/01.WNL.0000065916.25128.25","article-title":"Insulin increases CSF Abeta42 levels in normal older adults","volume":"60","author":"Watson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2013.12.012_bib0270","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer's disease","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0275","doi-asserted-by":"crossref","first-page":"306905","DOI":"10.5402\/2011\/306905","article-title":"Mechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease","volume":"2011","author":"Schuh","year":"2011","journal-title":"ISRN Neurol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0280","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1155\/NP.2005.311","article-title":"The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease","volume":"12","author":"Messier","year":"2005","journal-title":"Neural Plast"},{"key":"10.1016\/j.bcp.2013.12.012_bib0285","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","article-title":"Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor","volume":"22","author":"Xie","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0290","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2013.12.012_bib0295","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000283480","article-title":"Neuroinflammation \u2013 an early event in both the history and pathogenesis of Alzheimer's disease","volume":"7","author":"Eikelenboom","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0300","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jpsychires.2007.10.010","article-title":"Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort","volume":"42","author":"Blasko","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0305","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/187152710791012026","article-title":"Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence","volume":"9","author":"Szekely","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.bcp.2013.12.012_bib0310","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","article-title":"The role of inflammation in Alzheimer's disease","volume":"37","author":"Tuppo","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00702-003-0055-1","article-title":"Neuroinflammatory perspectives on the two faces of Alzheimer's disease","volume":"111","author":"Eikelenboom","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bcp.2013.12.012_bib0320","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","article-title":"Neuroinflammatory processes in Alzheimer's disease","volume":"117","author":"Heneka","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bcp.2013.12.012_bib0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.1999.tb00215.x","article-title":"Oxidative alterations in Alzheimer's disease","volume":"9","author":"Markesbery","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0330","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","article-title":"Targeting p38 MAPK pathway for the treatment of Alzheimer's disease","volume":"58","author":"Munoz","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2013.12.012_bib0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","article-title":"Ceramides in insulin resistance and lipotoxicity","volume":"45","author":"Summers","year":"2006","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0340","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.3233\/JAD-2012-111727","article-title":"Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed","volume":"30","author":"de la Monte","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0345","first-page":"128","article-title":"CSF and brain indices of insulin resistance, oxidative stress and neuro-inflammation in early versus late Alzheimer's disease","volume":"3","author":"Lee","year":"2013","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"10.1016\/j.bcp.2013.12.012_bib0350","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1874609810801010030","article-title":"Inflammation in neurodegenerative disorders: friend or foe","volume":"1","author":"Galimberti","year":"2008","journal-title":"Curr Aging Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.exger.2009.10.011","article-title":"Growth factors and cytokines\/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer's disease and mild cognitive impairment","volume":"45","author":"Olson","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0360","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3233\/JAD-2009-1013","article-title":"Oxidative stress in diabetes and Alzheimer's disease","volume":"16","author":"Reddy","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0365","first-page":"441","article-title":"Carbonyl proteins as a clinical marker in Alzheimer's disease and its relation to tryptophan degradation and immune activation","volume":"56","author":"Greilberger","year":"2010","journal-title":"Clin Lab"},{"key":"10.1016\/j.bcp.2013.12.012_bib0370","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2008.05.050","article-title":"Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice","volume":"440","author":"Gu","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bcp.2013.12.012_bib0375","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adhes Migrat"},{"key":"10.1016\/j.bcp.2013.12.012_bib0380","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/CCLM.2011.079","article-title":"Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease","volume":"49","author":"Rahmadi","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0385","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.exger.2010.03.001","article-title":"Advanced glycation end products as biomarkers and gerontotoxins \u2013 a basis to explore methylglyoxal-lowering agents for Alzheimer's disease","volume":"45","author":"Krautwald","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0390","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JAD-2003-5305","article-title":"Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection","volume":"5","author":"Chen","year":"2003","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0395","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jnr.10703","article-title":"Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells","volume":"73","author":"Tsukamoto","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","article-title":"Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease","volume":"10","author":"de la Monte","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0405","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-991513","article-title":"Endoplasmic reticulum stress and liver injury","volume":"27","author":"Kaplowitz","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0410","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0028-1091980","article-title":"Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease","volume":"28","author":"Malhi","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0415","first-page":"411","article-title":"Endoplasmic reticulum (ER) stress & diabetes","volume":"125","author":"Sundar-Rajan","year":"2007","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0420","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-2009-1098","article-title":"Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease","volume":"17","author":"de la Monte","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2013.12.012_bib0425","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1440-1746.2006.04581.x","article-title":"Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulum","volume":"21","author":"Kaplowitz","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0430","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.regpep.2011.11.008","article-title":"GLP-1 analogue, Liraglutide protects human umbilical vein endothelial cells against high glucose induced endoplasmic reticulum stress","volume":"174","author":"Schisano","year":"2012","journal-title":"Regul Pept"},{"key":"10.1016\/j.bcp.2013.12.012_bib0435","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4419-8969-7_8","article-title":"Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications","volume":"541","author":"Hoyer","year":"2004","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0440","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2001-12927","article-title":"Etiopathogenesis of nonalcoholic steatohepatitis","volume":"21","author":"Chitturi","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0445","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.exger.2009.11.007","article-title":"Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories","volume":"45","author":"Brewer","year":"2010","journal-title":"Exp Gerontol"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2013.12.012_bib0450","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1440-1746.2006.04640.x","article-title":"Role of mitochondria in non-alcoholic fatty liver disease","volume":"22","author":"Pessayre","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0455","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1471-4159.2006.04368.x","article-title":"Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein","volume":"101","author":"Grunblatt","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2013.12.012_bib0460","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00004872-200406000-00001","article-title":"Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled \u2018hypertensive nephrosclerosis\u2019","volume":"22","author":"Kincaid-Smith","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.bcp.2013.12.012_bib0465","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2169\/internalmedicine.44.548","article-title":"Insulin resistance contributes to obesity-related proteinuria","volume":"44","author":"Matsumoto","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0470","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-1998-1205","article-title":"Cerebrovascular pathology contributes to the heterogeneity of Alzheimer's disease","volume":"1","author":"Etiene","year":"1998","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0475","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.2337\/dc06-0243","article-title":"Brain aging in very old men with type 2 diabetes: the Honolulu-Asia aging study","volume":"29","author":"Korf","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2013.12.012_bib0480","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2174\/1874609811104020118","article-title":"Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: a missing link to therapeutic potential","volume":"4","author":"Sato","year":"2011","journal-title":"Curr Aging Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0485","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000325914","article-title":"Igf-I signaling and effects on longevity","volume":"68","author":"Holzenberger","year":"2011","journal-title":"Nestle Nutr Workshop Ser Pediatr Prog"},{"key":"10.1016\/j.bcp.2013.12.012_bib0490","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.mad.2012.03.003","article-title":"Manipulation of in vivo iron levels can alter resistance to oxidative stress without affecting ageing in the nematode C. elegans","volume":"133","author":"Valentini","year":"2012","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.bcp.2013.12.012_bib0495","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s11357-012-9491-x","article-title":"Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging","volume":"35","author":"Zemva","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.bcp.2013.12.012_bib0500","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1479-5876-9-103","article-title":"Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats","volume":"9","author":"Castilla-Cortazar","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0505","doi-asserted-by":"crossref","first-page":"e15767","DOI":"10.1371\/journal.pone.0015767","article-title":"Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes","volume":"6","author":"Luque","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.bcp.2013.12.012_bib0510","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/gerona\/gls100","article-title":"Methylglyoxal, cognitive function and cerebral atrophy in older people","volume":"68","author":"Srikanth","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0515","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bcp.2012.05.007","article-title":"Insulin resistance in the brain: an old-age or new-age problem","volume":"84","author":"Williamson","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0520","first-page":"474","article-title":"Interferon-gamma \u2013 inducible inflammation: contribution to aging and aging-associated psychiatric disorders","volume":"2","author":"Oxenkrug","year":"2011","journal-title":"Aging Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0525","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/13813455.2011.577435","article-title":"Age-associated development of inflammation in Wistar rats: effects of caloric restriction","volume":"117","author":"Horrillo","year":"2011","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.bcp.2013.12.012_bib0530","doi-asserted-by":"crossref","first-page":"98","DOI":"10.18632\/aging.100431","article-title":"Inflammatory cause of metabolic syndrome via brain stress and NF-kappaB","volume":"4","author":"Cai","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2013.12.012_bib0535","doi-asserted-by":"crossref","first-page":"G697","DOI":"10.1152\/ajpgi.00426.2010","article-title":"Obesity, diabetes mellitus, and liver fibrosis","volume":"300","author":"Chiang","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0540","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bcp.2013.12.012_bib0545","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3233\/JAD-2009-1070","article-title":"Epidemiological trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis","volume":"17","author":"de la Monte","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0550","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-2009-0984","article-title":"Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis","volume":"16","author":"Lyn-Cook","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0555","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes: evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0560","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1262-3636(08)74600-7","article-title":"Insulin resistance and steatosis in humans","volume":"34","author":"Capeau","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.bcp.2013.12.012_bib0565","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mol.0000319118.44995.9a","article-title":"Free fatty acids and skeletal muscle insulin resistance","volume":"19","author":"Kraegen","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0570","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneur.64.4.570","article-title":"Relation of diabetes to mild cognitive impairment","volume":"64","author":"Luchsinger","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0575","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment","volume":"4","author":"Craft","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0580","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.soard.2009.05.008","article-title":"Evidence of executive dysfunction in extremely obese adolescents: a pilot study","volume":"5","author":"Lokken","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0585","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.comppsych.2006.05.001","article-title":"Elevated body mass index is associated with executive dysfunction in otherwise healthy adults","volume":"48","author":"Gunstad","year":"2007","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.bcp.2013.12.012_bib0590","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/156720507780362191","article-title":"Metabolic syndrome and cognitive decline","volume":"4","author":"Yaffe","year":"2007","journal-title":"Curr Alzheimer Res"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2013.12.012_bib0595","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neurobiolaging.2005.09.003","article-title":"Studies of the effects of high fat diets on cognitive function in a rat model","volume":"26","author":"Winocur","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bcp.2013.12.012_bib0600","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-2008-15103","article-title":"Limited Alzheimer-type neurodegeneration in experimental obesity and Type 2 diabetes mellitus","volume":"15","author":"Moroz","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0605","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3233\/JAD-2010-100768","article-title":"Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease","volume":"22","author":"Baker","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0610","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archneurol.2009.307","article-title":"Effects of aerobic exercise on mild cognitive impairment: a controlled trial","volume":"67","author":"Baker","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0615","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/appe.2000.0389","article-title":"The effect of weight-loss dieting on cognitive performance and psychological well-being in overweight women","volume":"36","author":"Bryan","year":"2001","journal-title":"Appetite"},{"key":"10.1016\/j.bcp.2013.12.012_bib0620","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2010-100897","article-title":"Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease","volume":"22","author":"Gu","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0625","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1262-3636(07)70298-7","article-title":"Diabetes mellitus and dementia","volume":"32","author":"Pasquier","year":"2006","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.bcp.2013.12.012_bib0630","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001854","article-title":"Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease","volume":"11","author":"Martins","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bcp.2013.12.012_bib0635","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11910-007-0058-7","article-title":"Type 2 diabetes and risk of cognitive impairment and dementia","volume":"7","author":"Whitmer","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.bcp.2013.12.012_bib0640","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbadis.2008.08.005","article-title":"Human cerebral neuropathology of Type 2 diabetes mellitus","volume":"1792","author":"Nelson","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2013.12.012_bib0645","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2013.12.012_bib0650","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6823-10-4","article-title":"Early limited nitrosamine exposures exacerbate high fat diet-mediated type2 diabetes and neurodegeneration","volume":"10","author":"Tong","year":"2010","journal-title":"BMC Endocr Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0655","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/156720507780362047","article-title":"Body mass index in midlife and risk of Alzheimer disease and vascular dementia","volume":"4","author":"Whitmer","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0660","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10620-007-9896-z","article-title":"Cognitive dysfunction in chronic hepatitis C: a review","volume":"53","author":"Perry","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0665","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11904-006-0013-2","article-title":"Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV","volume":"3","author":"Weiss","year":"2006","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.bcp.2013.12.012_bib0670","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3233\/JAD-2009-1115","article-title":"Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease","volume":"17","author":"Tong","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0675","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/gcen.1999.7265","article-title":"Effects of insulin on lipid metabolism of larvae and metamorphosing landlocked sea lamprey, Petromyzon marinus","volume":"114","author":"Kao","year":"1999","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0680","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bcp.2013.12.012_bib0685","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.plipres.2009.03.002","article-title":"Glycosphingolipids and insulin resistance","volume":"48","author":"Langeveld","year":"2009","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0690","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.psy.0000221276.17823.df","article-title":"Depression, anxiety, and nonalcoholic steatohepatitis","volume":"68","author":"Elwing","year":"2006","journal-title":"Psychosom Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0695","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11011-011-9269-3","article-title":"Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy","volume":"27","author":"Felipo","year":"2011","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0700","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000088306","article-title":"The neuropsychological profile of alcohol-related dementia suggests cortical and subcortical pathology","volume":"20","author":"Schmidt","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.bcp.2013.12.012_bib0705","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/alcalc\/agn118","article-title":"The Korsakoff syndrome: clinical aspects, psychology and treatment","volume":"44","author":"Kopelman","year":"2009","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0710","article-title":"Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed","volume":"30","author":"de la Monte","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0715","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1750-1326-4-54","article-title":"Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment","volume":"4","author":"de la Monte","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bcp.2013.12.012_bib0720","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3233\/JAD-2010-091726","article-title":"Ceramide-mediated insulin resistance and impairment of cognitive-motor functions","volume":"21","author":"de la Monte","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0725","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-2009-0983","article-title":"Mechanisms of ceramide-mediated neurodegeneration","volume":"16","author":"Tong","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0730","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1042\/bst0320144","article-title":"Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer's disease","volume":"32","author":"Alessenko","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bcp.2013.12.012_bib0735","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","article-title":"Altered lipid metabolism in brain injury and disorders","volume":"49","author":"Adibhatla","year":"2008","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bcp.2013.12.012_bib0740","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0745","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2337\/dc11-0308","article-title":"Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham offspring study","volume":"34","author":"Tan","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2013.12.012_bib0750","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.22062","article-title":"Visceral fat is associated with lower brain volume in healthy middle-aged adults","volume":"68","author":"Debette","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0755","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000296071","article-title":"Metabolic syndrome is associated with learning and recall impairment in middle age","volume":"29","author":"Hassenstab","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.bcp.2013.12.012_bib0760","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JAD-2010-100015","article-title":"Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?","volume":"21","author":"Frisardi","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0765","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/ATVBAHA.112.252759","article-title":"Impact of metabolic syndrome on cognition and brain: a selected review of the literature","volume":"32","author":"Yates","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0770","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbadis.2011.06.011","article-title":"Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging","volume":"1822","author":"Burns","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2013.12.012_bib0775","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-2010-091687","article-title":"Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention?","volume":"20","author":"Luchsinger","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0780","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejim.2007.02.034","article-title":"Evolving trends in nonalcoholic fatty liver disease","volume":"19","author":"Delgado","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0785","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156720507780362155","article-title":"Next steps in Alzheimer's disease research: interaction between epidemiology and basic science","volume":"4","author":"Launer","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0790","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ncpgasthep0879","article-title":"Evaluation and management of obesity-related nonalcoholic fatty liver disease","volume":"4","author":"Nugent","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0795","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1301\/nr.2007.dec.S152-S156","article-title":"Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders","volume":"65","author":"Pradhan","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.bcp.2013.12.012_bib0800","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.14.185","article-title":"Non-alcoholic fatty liver disease and the metabolic syndrome: an update","volume":"14","author":"Rector","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0805","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/bj1100039","article-title":"Nitrosamine-induced carcinogenesis. The alklylation of nucleic acids of the rat by N-methyl-N-nitrosourea, dimethylnitrosamine, dimethyl sulphate and methyl methanesulphonate","volume":"110","author":"Swann","year":"1968","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2013.12.012_bib0810","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0041-008X(92)90151-H","article-title":"Dimethylnitrosamine (DMN)-induced IL-1 beta, TNF-alpha, and IL-6 inflammatory cytokine expression","volume":"116","author":"Schook","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0815","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cld.2007.02.013","article-title":"Metabolic syndrome and NASH","volume":"11","author":"Marchesini","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0820","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1567205043480555","article-title":"The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease","volume":"1","author":"Nicolls","year":"2004","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0825","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clnu.2007.02.002","article-title":"Update on non-alcoholic fatty liver disease in children","volume":"26","author":"Papandreou","year":"2007","journal-title":"Clin Nutr"},{"key":"10.1016\/j.bcp.2013.12.012_bib0830","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3748\/wjg.14.193","article-title":"Nonalcoholic fatty liver disease and mitochondrial dysfunction","volume":"14","author":"Wei","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0835","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/RTPM1PY6YGBL2G2R","article-title":"Pathology of nonalcoholic fatty liver disease","volume":"128","author":"Yeh","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0840","first-page":"129","article-title":"Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)","volume":"51","author":"Doi","year":"1975","journal-title":"Nippon Naibunpi Gakkai Zasshi"},{"key":"10.1016\/j.bcp.2013.12.012_bib0845","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0850","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s007020050232","article-title":"Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)","volume":"106","author":"Hoyer","year":"1999","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bcp.2013.12.012_bib0855","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2006.02.008","article-title":"High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice","volume":"246","author":"Iwai","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2013.12.012_bib0860","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1073\/pnas.74.6.2485","article-title":"Studies of streptozotocin-induced insulitis and diabetes","volume":"74","author":"Rossini","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2013.12.012_bib0865","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0006-2952(98)00370-0","article-title":"Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin","volume":"57","author":"Murata","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0870","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-5793(88)80938-4","article-title":"Enhancement by streptozotocin of O2-radical generation by the xanthine oxidase system of pancreatic beta-cells","volume":"239","author":"Nukatsuka","year":"1988","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2013.12.012_bib0875","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1734-1140(11)70504-7","article-title":"Increases in beta-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-kappaB pathway activation","volume":"63","author":"Cai","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bcp.2013.12.012_bib0880","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/ATVBAHA.111.228924","article-title":"Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy","volume":"31","author":"Devaraj","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0885","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1464-5491.2000.00259.x","article-title":"Radicals and oxidative stress in diabetes","volume":"17","author":"West","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.bcp.2013.12.012_bib0890","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-3-211-98811-4_32","article-title":"Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease","volume":"106","author":"Labak","year":"2010","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.bcp.2013.12.012_bib0895","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.metabol.2010.12.001","article-title":"Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo","volume":"60","author":"Wang","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2013.12.012_bib0900","first-page":"259","article-title":"Desensitization of brain insulin receptor. Effect on glucose\/energy and related metabolism","volume":"44","author":"Hoyer","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.bcp.2013.12.012_bib0905","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1037\/0735-7044.112.5.1199","article-title":"Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats","volume":"112","author":"Lannert","year":"1998","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0910","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/jphp.12051","article-title":"Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver","volume":"65","author":"Shi","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0915","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.bbagen.2012.10.016","article-title":"Insulin sensitization via partial agonism of PPARgamma and glucose uptake through translocation and activation of GLUT4 in PI3K\/p-Akt signaling pathway by embelin in type 2 diabetic rats","volume":"1830","author":"Gandhi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2013.12.012_bib0920","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/JME-11-0127","article-title":"Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states","volume":"48","author":"Moreno","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0925","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0736-5748(94)90053-1","article-title":"Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats","volume":"12","author":"Duelli","year":"1994","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0930","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-1218(96)90038-5","article-title":"DNA damage induced by seven N-nitroso compounds in primary cultures of human and rat kidney cells","volume":"368","author":"Robbiano","year":"1996","journal-title":"Mutat Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0935","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3233\/JAD-2010-1240","article-title":"Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation","volume":"19","author":"Cataldo","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0940","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/02646830500382037","article-title":"Clinical aspects of inflammation in Alzheimer's disease","volume":"17","author":"Rosenberg","year":"2005","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.bcp.2013.12.012_bib0945","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.bcp.2013.12.012_bib0950","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","article-title":"Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease","volume":"32","author":"Katsel","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0955","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MOL.0b013e3283373b66","article-title":"Sphingolipids and insulin resistance: the five Ws","volume":"21","author":"Summers","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.bcp.2013.12.012_bib0960","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib0965","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1301\/nr.2007.jun.S39-S46","article-title":"Lipid mediators of insulin resistance","volume":"65","author":"Holland","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.bcp.2013.12.012_bib0970","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1007\/s00125-011-2127-3","article-title":"Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance","volume":"54","author":"Lipina","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2013.12.012_bib0975","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","article-title":"Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009","volume":"53","author":"DeFronzo","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2013.12.012_bib0980","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11154-011-9168-2","article-title":"Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity","volume":"12","author":"Eckardt","year":"2011","journal-title":"Rev Endocr Metab Dis"},{"key":"10.1016\/j.bcp.2013.12.012_bib0985","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/iub.142","article-title":"Intramuscular lipid metabolism, insulin action, and obesity","volume":"61","author":"Consitt","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bcp.2013.12.012_bib0990","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","article-title":"Ceramide synthesis and metabolism as a target for cancer therapy","volume":"206","author":"Reynolds","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2013.12.012_bib0995","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MCO.0b013e328042ba90","article-title":"Free fatty acids and insulin resistance","volume":"10","author":"Delarue","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.bcp.2013.12.012_bib1000","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/scdb.1997.0153","article-title":"Sphingomyelinases in cell regulation","volume":"8","author":"Liu","year":"1997","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.bcp.2013.12.012_bib1005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.lfs.2008.01.022","article-title":"The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice","volume":"82","author":"Cong","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2013.12.012_bib1010","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2337\/db07-0111","article-title":"Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity","volume":"56","author":"Kolak","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2013.12.012_bib1015","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1111\/j.1460-9568.2007.05557.x","article-title":"Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells","volume":"25","author":"Arboleda","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bcp.2013.12.012_bib1020","doi-asserted-by":"crossref","first-page":"20148","DOI":"10.1074\/jbc.M412769200","article-title":"Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling","volume":"280","author":"Chavez","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.12.012_bib1025","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.274.29.20313","article-title":"Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid","volume":"274","author":"Chalfant","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.12.012_bib1030","first-page":"179","article-title":"Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis","volume":"vol. 1","author":"de la Monte","year":"2011"},{"key":"10.1016\/j.bcp.2013.12.012_bib1035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156720512799015037","article-title":"Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease","volume":"9","author":"de la Monte","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bcp.2013.12.012_bib1040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbalip.2008.04.008","article-title":"Regulation and functions of sphingosine kinases in the brain","volume":"1781","author":"Bryan","year":"2008","journal-title":"Biochim Biophys Acta"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521300796X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521300796X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:03:55Z","timestamp":1746097435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521300796X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":208,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S000629521300796X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2013.12.012","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain metabolic dysfunction at the core of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2013.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}